Current Understanding of Epigenetics Driven Therapeutic Strategies in Colorectal Cancer Management
- 1 October 2021
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Endocrine, Metabolic & Immune Disorders - Drug Targets
- Vol. 21 (10), 1882-1894
- https://doi.org/10.2174/1871530321666210219155544
Abstract
Colorectal cancer is known to be the paramount reason for cancer deaths around the globe. It occurs due to the aggregation of epigenetic and genetic alterations in colon epithelial cells that transmute them into adenocarcinomas. Epigenetic mechanisms are interpreted as the changes in expression of the gene which is not associated with the alterations in the principal DNA sequence, while genetic changes involve modifications in oncogenes and tumor suppressor genes. The changes in the epigenetic in colon cancer that transmute colonic epithelial cells include chromatin modifications, microRNA expression, telomere length, and DNA methylation. DNA hypermethylation causes down-regulation and unsuitable expression of specific microRNA which can behave like tumor suppressor genes. Histone modifications can also influence the chromatin remodeling and the gene expression, hence performs an eminent function in silencing of the gene in colon cancer. Moreover, the telomere/telomerase interaction is a prime mechanism to embrace both cellular replicative potential and genomic instability and its malfunction plays a primary role in colon cancer. Deducing the genesis and the function of epigenetic abnormality in colon cancer pathogenesis will head to a potent prevention and therapeutic approach for colon cancer patients. Epigenetic drugs which emphasizes the convertible essence of epigenetic occurrences have accompanied the probability of epigenetic approach as a treatment alternative in colon cancer. Hence, this review is undertaken to critically envelop the recent advance events in colorectal cancer therapies with a special emphasis on remedies targeting epigenetic modulators and future challenges towards therapeutic interventions.Keywords
Funding Information
- SERB-DST (ECR/2017/001066)
This publication has 49 references indexed in Scilit:
- Epigenetic changes of DNA repair genes in cancerJournal of Molecular Cell Biology, 2011
- Regulation of PTEN expression by the SWI/SNF chromatin-remodelling protein BRG1 in human colorectal carcinoma cellsBritish Journal of Cancer, 2010
- Hereditary and Familial Colon CancerGastroenterology, 2010
- Global Levels of Histone Modifications Predict Prognosis in Different CancersThe American Journal of Pathology, 2009
- Catalysis and substrate selection by histone/protein lysine acetyltransferasesCurrent Opinion in Structural Biology, 2008
- Global Histone H4 Acetylation and HDAC2 Expression in Colon Adenoma and CarcinomaDigestive Diseases and Sciences, 2008
- Chromatid cohesion defects may underlie chromosome instability in human colorectal cancersProceedings of the National Academy of Sciences of the United States of America, 2008
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancerNature Genetics, 2005
- Anti-cancer effects of butyrate: use of micro-array technology to investigate mechanismsProceedings of the Nutrition Society, 2003